A first-in-class, first-in-human phase I trial of KPT-330 (selinexor), a selective inhibitor of nuclear export (SINE) in patients (pts) with advanced solid tumors

التفاصيل البيبلوغرافية
العنوان: A first-in-class, first-in-human phase I trial of KPT-330 (selinexor), a selective inhibitor of nuclear export (SINE) in patients (pts) with advanced solid tumors
المؤلفون: Morten Mau-Soerensen, Albiruni R. A. Razak, Anthony Frank Shields, Nashat Y. Gabrail, John F. Gerecitano, Sharon Shacham, Ulrik Niels Lassen, Tami Rashal, Jennifer Cooksey, Yosef Landesman, Gregory Pond, Amit M. Oza, Michael Kauffman, Lillian L. Siu, Philippe L. Bedard, Hemchandra Mahaseth, Mansoor Raza Mirza, Amit Mahipal
المصدر: Journal of Clinical Oncology. 32:2537-2537
بيانات النشر: American Society of Clinical Oncology (ASCO), 2014.
سنة النشر: 2014
مصطلحات موضوعية: Cancer Research, Oncology
تدمد: 1527-7755
0732-183X
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::de97cbad672bec6db931775e920aea4dTest
https://doi.org/10.1200/jco.2014.32.15_suppl.2537Test
رقم الانضمام: edsair.doi...........de97cbad672bec6db931775e920aea4d
قاعدة البيانات: OpenAIRE